CHF6563

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF6563, covering 2023-08-03 to 2023-08-03. Get the full timeline:

Most recent: Clinical Trial Update: CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome [Phase 2]